Clinical Risk Grouping Solution Market Report 2026

The clinical risk grouping solution market size has grown rapidly in recent years. It will grow from $0.69 billion in 2025 to $0.77 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to expansion of healthcare data digitization, rising chronic disease burden, adoption of risk-based reimbursement models, increased payer focus on cost containment, growing use of healthcare analytics platforms.

The clinical risk grouping solution market size is expected to see rapid growth in the next few years. It will grow to $1.23 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to increasing investments in ai-driven clinical analytics, rising demand for population health management solutions, expansion of cloud-based healthcare platforms, growing focus on predictive care planning, increasing regulatory emphasis on data-driven decision-making. Major trends in the forecast period include increasing adoption of predictive risk stratification models, growing use of real-time population health analytics, expansion of value-based care enablement tools, rising integration with electronic health records, enhanced focus on cost and outcome transparency.

The increasing adoption of electronic health records (EHRs) is expected to drive the growth of the clinical risk grouping solution market in the coming years. Electronic health records (EHRs) are digital versions of patients’ paper charts that offer real-time, patient-centered records accessible to authorized healthcare professionals. The rising adoption of EHRs is primarily fueled by the growing need for efficient data management, as healthcare providers seek to streamline patient information storage, enhance accessibility, and improve coordination across departments to support better clinical decision-making and patient outcomes. EHR adoption supports clinical risk grouping solutions by providing comprehensive, up-to-date patient data, enabling accurate risk stratification and more effective population health management. For instance, in July 2024, according to the European Commission, a Belgium-based organization, the Digital Decade eHealth Indicator Study reported that average EU access to electronic health records via online portals increased to 79%, up from 72% in 2022. Therefore, the rising adoption of electronic health records (EHRs) is driving the growth of the clinical risk grouping solution market.

Major companies operating in the clinical risk grouping solution market are focusing on developing advanced solutions, such as comprehensive risk adjustment platforms, to improve predictive analytics, population health management, and care quality assessment compared to traditional manual or fragmented risk scoring approaches. Risk adjustment platforms integrate clinical, claims, and demographic data to stratify patient populations, identify high-risk members, and support value-based care initiatives by enabling more accurate reimbursement and resource allocation. For instance, in March 2025, Milliman MedInsight, a US-based healthcare analytics company, launched a comprehensive risk adjustment platform aimed at improving performance across health plans and provider networks. The platform combines clinical data, claims records, and predictive algorithms to generate risk scores, identify gaps in care, and support proactive interventions. Key features include customizable reporting dashboards, real-time analytics, and integration with EHRs and claims systems. Applications span payers, accountable care organizations, and population health programs, offering benefits such as enhanced risk stratification accuracy, optimized resource use, improved quality of care, and better alignment with value-based reimbursement models.

In October 2023, Optum Health Solutions (UK) Ltd., a UK-based healthcare services company, acquired EMIS Group plc for $1.5 billion (£1.2 billion). Through this acquisition, Optum Health Solutions aims to strengthen its position in the UK healthcare market by integrating EMIS Group’s advanced clinical software and data analytics capabilities to enable more efficient, technology-driven healthcare delivery. EMIS Group plc is a UK-based company specializing in clinical risk grouping solutions.

Major companies operating in the clinical risk grouping solution market are Optum Inc, 3M Corporation, Solventum, Conduent Inc, Epic Systems Corporation, Cotiviti Inc, Health Catalyst Inc, Edifecs Inc, Innovaccer Inc, Cedar Gate Technologies, Reveleer, ZeOmega, MedeAnalytics Inc, Lightbeam Health Solutions, Apixio, HealthEC LLC, CareEvolution, HBI Solutions, 4S Information Systems, Milliman Inc, Change Healthcare, Verisk Health, Arcadia Solutions.

North America was the largest region in the clinical risk grouping solution market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical risk grouping solution market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical risk grouping solution market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the clinical risk grouping solution market by increasing costs of imported servers, networking equipment, cloud infrastructure components, and advanced analytics software tools. Healthcare providers and payers in North America and Europe are most affected due to reliance on globally sourced IT infrastructure, while Asia-Pacific faces higher implementation costs for enterprise healthcare analytics platforms. These tariffs are raising deployment and integration expenses for large healthcare systems. At the same time, they are encouraging regional software development, local data center investments, and adoption of cost-optimized cloud-native risk analytics solutions.

The clinical risk grouping solution market research report is one of a series of new reports that provides clinical risk grouping solution market statistics, including clinical risk grouping solution industry global market size, regional shares, competitors with a clinical risk grouping solution market share, detailed clinical risk grouping solution market segments, market trends and opportunities, and any further data you may need to thrive in the clinical risk grouping solution industry. This clinical risk grouping solution market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A clinical risk grouping (CRG) solution is a healthcare analytics system that organizes patients into clinically meaningful and mutually exclusive risk categories based on their medical history, diagnoses, procedures, and other health-related information. This classification enables healthcare providers, payers, and policymakers to predict healthcare utilization, manage population health, and allocate resources effectively.

The primary components of a clinical risk grouping solution are software and services. CRG software is a digital tool that categorizes patients according to health risk to support care management, reduce costs, and facilitate data-driven decision-making. The solution encompasses various products, including dashboard analytics, scorecards and data visualization tools, and risk reporting solutions, and can be deployed via private, public, or hybrid cloud environments. Key applications include population health management, chronic disease management, clinical decision support, fraud detection and prevention, and other healthcare-related functions. The solution is employed by a range of end users, such as hospitals and clinics, ambulatory surgical centers, long-term care facilities, and others.

The clinical risk grouping solution market consists of revenues earned by entities by providing services such as risk stratification, predictive analytics, patient classification, clinical decision support, population health management, claims and billing optimization, care coordination, and regulatory compliance and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.